Cigarette smoke exposure attenuates cytokine production by mouse alveolar macrophages

Gordon J Gaschler1, Caleb C J Zavitz, Carla M T Bauer

  • 1McMaster University, Department of Pathology and Molecular Medicine, 1200 Main Street West, Hamilton, ON, L8N 3Z5 Canada.

Insights

Cigarette smoke exposure weakens alveolar macrophages' immune response to pathogens. This impaired function, affecting cytokine production, is reversible after quitting smoking.

Area of Science:

  • Immunology
  • Respiratory Medicine
  • Toxicology

Background:

  • Alveolar macrophages (aMs) are critical for lung defense against infections.
  • Cigarette smoke is a major environmental risk factor for respiratory diseases.
  • Understanding smoke's impact on macrophage function is vital for respiratory health.

Purpose of the Study:

  • To investigate how cigarette smoke exposure affects alveolar macrophage responses to innate immune stimuli.
  • To explore the underlying molecular mechanisms of this effect.
  • To determine if the observed effects are reversible.

Main Methods:

  • Mice were exposed to cigarette smoke (nose-only or whole-body) for 8 weeks.
  • Alveolar macrophages were isolated and stimulated with pattern recognition receptor (PRR) agonists (pI:C, LPS, Nlr agonists).
  • Cytokine production, RNA levels, cell viability, TLR expression, and transcription factor nuclear translocation (NF-κB, AP-1) were analyzed.

Main Results:

  • Smoke-exposed aMs showed significantly reduced production of inflammatory cytokines (TNF-α, IL-6) and chemokines (RANTES) after PRR stimulation.
  • This attenuation was linked to decreased NF-κB and increased AP-1 nuclear translocation.
  • The impaired cytokine response was reversible upon smoking cessation.
  • Effects were observed across different PRR pathways, indicating broad impact.

Conclusions:

  • Cigarette smoke exposure significantly impairs alveolar macrophage immune responses to common respiratory pathogens.
  • The study reveals specific molecular mechanisms (NF-κB, AP-1 pathways) involved in smoke-induced immune suppression.
  • Reversibility of these effects highlights the potential benefits of smoking cessation for lung immunity.

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.